share

Emerging Clinical Trial Opportunities for Individuals with SCI: From Stem Cells to Probiotics

Your browser is not able to display this multimedia content.

The developing plans for the first ever formal human clinical trial of a human embryonic stem cell derived therapy for SCI and new opportunities for individuals with SCI to be involved in clinical trials addressing secondary medical complications. The opportunities arise from the rollout of the ONF SCI Research agendas for Urological Care and Management of Pressure Sores.

Speaker: Dr. Hayes, PhD, Professor in the dept., of Physical Medicine & Rehabilitation, Dept. of Physiology and Pharmacology, U of Western; Senior Scientist at the Lawson Health Research Inst., London, ON

in